Clinical Whole Genome Sequencing for Clarithromycin and Amikacin Resistance Prediction and Subspecies Identification of Mycobacterium abscessus
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 23 (11) , 1460-1467
Abstract
No abstract availableKeywords
Funding Information
- University of California, Los Angeles
This publication has 34 references indexed in Scilit:
- New Rapid Scheme for Distinguishing the Subspecies of the Mycobacterium abscessus Group and Identifying Mycobacterium massiliense Isolates with Inducible Clarithromycin ResistanceJournal of Clinical Microbiology, 2013
- Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung DiseasesJournal of Clinical Microbiology, 2012
- Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41)Journal of Antimicrobial Chemotherapy, 2012
- Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessusJournal of Antimicrobial Chemotherapy, 2011
- Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm (41) and rrl SequencingAntimicrobial Agents and Chemotherapy, 2011
- Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) StrainsJournal of Clinical Microbiology, 2011
- Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense , and Mycobacterium bolletiiJournal of Clinical Microbiology, 2009
- A Novel Gene,erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates ofMycobacterium abscessusbut Is Absent fromMycobacterium chelonaeAntimicrobial Agents and Chemotherapy, 2009
- rpoB -Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing MycobacteriaJournal of Clinical Microbiology, 2003
- A Single 16S Ribosomal RNA Substitution Is Responsible for Resistance to Amikacin and Other 2‐Deoxystreptamine Aminoglycosides inMycobacterium abscessusandMycobacterium chelonaeThe Journal of Infectious Diseases, 1998